202 results on '"Baksi, A. John"'
Search Results
2. Role of serial 18F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosis
3. Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
4. Performance of artificial intelligence for biventricular cardiovascular magnetic resonance volumetric analysis in the clinical setting
5. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
6. Erratum for: Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity
7. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy
8. Heart Rate as a Marker of Relapse During Withdrawal of Therapy in Recovered Dilated Cardiomyopathy
9. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies
10. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
11. Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy
12. Diagnostic imaging of cardiac amyloidosis
13. Phenotype, outcomes and natural history of early‐stage non‐ischaemic cardiomyopathy
14. Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease
15. Improving description & understanding of the aortic pressure waveform in humans, using wave intensity analysis
16. Exercise-Induced Reversible Apical Ballooning in a Patient With Previous Takotsubo Syndrome and Ongoing Symptoms
17. Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
18. A phenotypic taxonomy of hypertrophic cardiomyopathy
19. MULTI-CHAMBER MYOCARDIAL STRAIN ANALYSIS FOR THE PREDICTION OF ACTIVE INFLAMMATION IN CARDIAC SARCOIDOSIS
20. CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CARDIAC SARCOIDOSIS WHO RECEIVED CARDIAC RESYNCHRONISATION THERAPY: COMPARISON WITH DILATED CARDIOMYOPATHY AND ISCHAEMIC CARDIOMYOPATHY
21. An unusual cause of ventricular tachycardia in a 50 years old man
22. Morphology
23. Cardiac MRI improves cardiovascular risk stratification in hazardous occupations
24. Arrhythmias in Viral Myocarditis and Pericarditis
25. Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy—a case report
26. Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy
27. The addition of genetic testing and cardiovascular magnetic resonance to routine clinical data for stratification of etiology in dilated cardiomyopathy
28. Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
29. MODE OF PRESENTATION, PROGNOSIS AND PREDICTORS OF OUTCOME IN A CONTEMPORARY CARDIAC SARCOIDOSIS POPULATION
30. LEFT VENTRICULAR EJECTION FRACTION MEASURED WITH SAME DAY 2D ECHOCARDIOGRAPHY AND CMR IN PATIENTS WITH SUSPECTED CARDIOTOXICITY
31. Performance of Artificial Intelligence for Biventricular Cardiovascular Magnetic Resonance Volumetric Analysis in the Clinical Setting
32. Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
33. Myocardial edema in Takotsubo syndrome mimicking apical hypertrophic cardiomyopathy: An insight into diagnosis by cardiovascular magnetic resonance
34. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices
35. Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
36. Clinical Significance of Partial Anomalous Pulmonary Venous Connections (Isolated and Atrial Septal Defect Associated) Determined by Cardiovascular Magnetic Resonance
37. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices.
38. Salvage assessment with cardiac MRI following acute myocardial infarction underestimates potential for recovery of systolic strain
39. Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants
40. Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED‐HF
41. Reversible exercise-induced left ventricular dysfunction in symptomatic patients with previous Takotsubo syndrome: insights from stress echocardiography
42. Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
43. The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases
44. An unusual cause of ventricular tachycardia in a 50 years old man
45. Reversible exercise-induced left ventricular dysfunction in symptomatic patients with previous Takotsubo syndrome: insights from stress echocardiography.
46. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial
47. Outcome in dilated cardiomyopathy related to the extent, location and pattern of late gadolinium enhancement
48. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
49. High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis
50. Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HF.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.